BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML

por Lin, W-H, Jiaang, W-T, Chen, C-W, Yen, K-J, Hsieh, S-Y, Yen, S-C, Chen, C-P, Chang, K-Y, Chang, C-Y, Chang, T-Y, Huang, Y-L, Yeh, T-K, Chao, Y-S, Chen, C-T, Hsu, J T-A
Publicado 2012